Skip to main content

How long has Otezla been on the market?

Medically reviewed by Carmen Pope, BPharm. Last updated on July 31, 2023.

Official answer

by Drugs.com

Otezla was first approved for the treatment of psoriatic arthritis on March 21st, 2014 by the FDA and was on the market soon after (by the end of March 2014). Later that year, approval was granted for using Otezla for moderate to severe psoriasis (Sept 23, 2014), and a few years later, for oral ulcers associated with Behçet's disease (July 19, 2019). Otezla is made by Amgen Inc, located in Thousand Oaks, California.

References

Otezla FDA Approval History. Updated 07/2019. https://www.drugs.com/history/otezla.html

Read next

Sotyktu and Otezla are both oral prescription medicines used to treat moderate-to-severe plaque psoriasis, but they work in different ways. Sotyktu blocks a protein called TYK2 (tyrosine kinase 2) to help lower inflammation and improve the severity and number of psoriasis lesions. Otezla works by blocking the phosphodiesterase type 4 (PDE4) enzyme to lower inflammation. Continue reading

Otezla may need to be taken long-term to manage the chronic conditions it is used to treat — psoriasis and psoriatic arthritis. But exactly how long it should be taken can vary because it can depend on factors like personal preference and condition severity. Continue reading

There is no evidence that it is unsafe to drink alcohol while taking Otezla. However, there are other reasons why it can be beneficial to limit alcohol consumption if you have psoriasis or psoriatic arthritis. Continue reading

Related medical questions

Drug information

Related support groups

Medical Disclaimer